WallStreetZenWallStreetZen

NASDAQ: KALV
Kalvista Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

KALV past revenue growth

How has KALV's revenue growth performed historically?
Company
N/A
Industry
145.73%
Market
17.2%
KALV's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
KALV's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

KALV earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$108.3M
Current Profit Margin
0%

KALV Return on Equity

Current Company
-86.1%
Current Industry
-63.5%
Current Market
188%
KALV's Return on Equity (-86.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when KALV announces earnings.

KALV Return on Assets

Current Company
-72.7%
Current Industry
2.9%
KALV is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

KALV Return on Capital Employed

Current Company
-114.19%
Current Industry
19.5%
KALV's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

KALV vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
KALV$0.00-$107.49M-$108.30M-100.00%N/A
FULC$2.81M-$95.16M-$97.34M-88.03%N/A
TBPH$57.42M-$40.77M-$55.19M-1.00%N/A
OCS$1.00M-$98.97M-$100.91M-1.76%N/A
APLT$9.99M-$119.41M-$119.76MN/AN/A
View Top Biotech Stocks

Kalvista Pharmaceuticals Earnings & Revenue FAQ

What were KALV's earnings last quarter?

On Invalid Date, Kalvista Pharmaceuticals (NASDAQ: KALV) reported Q4 2023 earnings per share (EPS) of -$0.84, up 12% year over year. Total Kalvista Pharmaceuticals earnings for the quarter were -$29.03 million. In the same quarter last year, Kalvista Pharmaceuticals's earnings per share (EPS) was -$0.75.

If you're new to stock investing, here's how to buy Kalvista Pharmaceuticals stock.

What was KALV's earnings growth in the past year?

As of Q2 2024, Kalvista Pharmaceuticals's earnings has grown year over year. Kalvista Pharmaceuticals's earnings in the past year totalled -$108.30 million.

What was KALV's revenue last quarter?

On Invalid Date, Kalvista Pharmaceuticals (NASDAQ: KALV) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Kalvista Pharmaceuticals's revenue was $0.00.

What was KALV's revenue growth in the past year?

As of Q2 2024, Kalvista Pharmaceuticals's revenue has grown null year over year. Kalvista Pharmaceuticals's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.